tiprankstipranks

Alan Fuhrman Insider Profile

4 Followers
Alan Fuhrman, Director at Loxo Oncology, holds 0.00 shares in Loxo Oncology (Ticker: LOXO), holds 12.85K shares in Tyra Bioscience (Ticker: TYRA), holds 53.40K shares in Esperion (Ticker: ESPR). Most recently, Alan Fuhrman ― shares of Loxo Oncology on ― for an estimated value of ―.
tipranks
Alan Fuhrman

Alan Fuhrman
Loxo Oncology (LOXO)
Director

Not Ranked
Alan Fuhrman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$923K
62.60%
22.53%
14.87%
0.00%
A breakdown of Alan Fuhrman's holdings

Insider Roles

Springworks Therapeutics
(SWTX)
Director
Tyra Bioscience
(TYRA)
CFO
Esperion
(ESPR)
Director
Achieve Life Sciences
(ACHV)
SVP & CFO
Roles that Alan Fuhrman holds in companies

Most Profitable Insider Trade

Stock:
Tyra Bioscience
(TYRA)
Rating:Informative Buy
Date:Nov 01, 2024 - Today
Return:-3.40%
The most profitable trade made by Alan Fuhrman

Alan Fuhrman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
LOXO
Loxo Oncology
$0.00
Springworks Therapeutics
May 17, 2024
Director
Uninformative Buy
$577.73K
Esperion
May 24, 2024
Director
Uninformative Buy
$137.25K
CMPI
Checkmate Pharmaceuticals
Tyra Bioscience
Nov 01, 2024
CFO
Informative Buy
151.91K
$207.90K
Achieve Life Sciences
SVP & CFO
$0.00
~AMBI
Ambit
List of latest transactions for each holding click on a transaction to see Alan Fuhrman's performance on stock

Alan Fuhrman insider profile FAQ

What is the percentage of profitable transactions made by Alan Fuhrman?
The percentage of profitable transactions made by Alan Fuhrman is ―.
    What is the average return per transaction made by Alan Fuhrman?
    The average return per transaction made by Alan Fuhrman is ―.
      What stocks does Alan Fuhrman hold?
      Alan Fuhrman holds: LOXO, SWTX, ESPR, CMPI, TYRA, ACHV, ~AMBI stocks.
        What was Alan Fuhrman’s latest transaction?
        Alan Fuhrman latest transaction was an Uninformative Buy of ―.
          What was Alan Fuhrman's most profitable transaction?
          Alan Fuhrman’s most profitable transaction was an Informative Buy of TYRA stock on November 1, 2024. The return on the trade was -3.40%.
            What is Alan Fuhrman's role in Loxo Oncology?
            Alan Fuhrman's role in Loxo Oncology is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.